LL-37 — 5 mg

LL-37 — 5 mg

LL-37 is a synthetic antimicrobial peptide widely studied in research settings for its selective interaction with innate immune and host-defense signaling pathways. Researchers examine it for how it influences immune response modulation, microbial defense mechanisms, and downstream inflammatory and tissue-related markers without broadly activating systemic endocrine pathways.

Key Research Observations on LL-37

Role in innate immune defense signaling
Research literature describes LL-37 as a human cathelicidin peptide involved in first-line immune defense, studied for its interaction with microbial membranes and immune signaling pathways.

Investigation of inflammatory modulation pathways
Studies explore how LL-37 may influence cytokine signaling, immune cell recruitment, and inflammatory balance in controlled experimental models.

Focus on epithelial and barrier-related signaling
Scientific research examines LL-37 for its role in epithelial defense mechanisms, barrier integrity signaling, and localized tissue response pathways.

Interest in wound response and tissue signaling research
Academic and preclinical investigations assess LL-37 for its downstream effects on cellular migration markers, angiogenic signaling, and tissue repair–associated pathways in research settings.